Why Us? >>

  • - Open Access
  • - Peer-reviewed
  • - Rapid publication
  • - Lifetime hosting
  • - Free indexing service
  • - Free promotion service
  • - More citations
  • - Search engine friendly

Free SCIRP Newsletters>>

Add your e-mail address to receive free newsletters from SCIRP.

 

Contact Us >>

WhatsApp  +86 18163351462(WhatsApp)
   
Paper Publishing WeChat
Book Publishing WeChat
(or Email:book@scirp.org)

Article citations

More>>

Gonzalez-Martin, A., Gladieff, L., Tholander, B., Stroyakovsky, D., Gore, M., Scambia, G., et al. (2013) Efficacy and Safety Results from OCTAVIA, a Single-Arm Phase II Study Evaluating Front-Line Bevacizumab, Carboplatin and Weekly Paclitaxel for Ovarian Cancer. European Journal of Cancer, 49, 3831-3838.

has been cited by the following article: